AVH on NASDAQ, page-309

Dude, AVH's excuse is that "The reprioritization of hospital resources to support COVID-19 readiness meant that our April results were the lowest monthly revenue and procedural volumes seen this calendar year. " PNV no doubt would have had to deal with the same issue... yet ends the quarter with sales 33% higher than the previous quarter. AVH ends up with no QoQ growth.

"If PNV was so impressive, why have they fallen from above $2.80 down to almost $2.20 in a month?"

If you want to compare share price performance of AVH vs PNV from before the start of COVID through to now, let's take a look. Here is the year to date share price performance in a chart:


PNV is up 15.6% for the year while AVH is down 47.66%. So yeah, one business has certainly been doing a better job at selling products and attracting investors... all without the window dressing of a Nasdaq listing.

Given you own both stocks, I would have thought this had been clear to you, but maybe the picture above will help.